Pancreatitis and gallbladder problems

Overview

Pancreatitis (inflammation of the pancreas) and gallbladder issues (like gallstones) are known, though rare, side effects of rapid weight loss and GLP-1 medications. For kidney patients, these conditions require swift diagnosis and management.

Why it's done and who it helps

• Symptom Awareness: Severe, persistent abdominal pain that radiates to the back is the hallmark of pancreatitis.
• Biliary Health: Rapid weight loss increases the risk of gallstones; we monitor for symptoms like "biliary colic" (upper right abdominal pain).
• Contraindications: A history of pancreatitis is usually an absolute contraindication to starting GLP-1 therapy.

ABCD and NICE Guidelines

• The Association of British Clinical Diabetologists (ABCD) recommends screening for a history of pancreatitis before prescribing GLP-1 RA.
• NICE TA875 and TA1026 highlight that while rare, these risks must be discussed with all patients.

Clinical Monitoring

Any new or severe abdominal pain is prioritised for review by Professor Mohammed Mahdi Althaf. We may check amylase or lipase levels if symptoms suggest a problem.

Preparing for your appointment

I had my gallbladder removed — is it safe?

Yes. Patients without a gallbladder are actually at *lower* risk for gallstone-related pancreatitis.

Is the risk high?

No. In clinical trials, the risk was less than 1%, but it is serious enough that we ensure every patient knows the warning signs.

References

• Association of British Clinical Diabetologists (ABCD) Position Statement
• NICE TA875: Semaglutide for obesity
• British Society of Gastroenterology (BSG) Guidelines

This article is general patient information reviewed by a consultant nephrologist. It is not individual medical advice; treatment decisions are made at a face-to-face consultation.